SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-24-008319
Filing Date
2024-01-30
Accepted
2024-01-30 17:00:28
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 tm244316-1_424b5.htm 424B5 894595
2 GRAPHIC lg_addextherapeutics-4c.jpg GRAPHIC 12767
3 GRAPHIC fc_inter-4clr.jpg GRAPHIC 46943
4 GRAPHIC fc_exter-4clr.jpg GRAPHIC 44342
5 GRAPHIC fc_mate-4clr.jpg GRAPHIC 64298
6 GRAPHIC fc_early-4clr.jpg GRAPHIC 54356
  Complete submission text file 0001104659-24-008319.txt   1201688
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-255089 | Film No.: 24579010
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)